3FI
GILD icon

3 Factor Indexing’s Gilead Sciences GILD Stock Holding History

3 Factor Indexing’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$759 Hold
6
– – ﹤0.01% 164
2026
Q1 		$837 Buy
+6
New +$840 ﹤0.01% 158

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

3 Factor Indexing's GILD Position: Q2 2026 in Review

3 Factor Indexing held its Gilead Sciences (GILD) position steady in Q2 2026 at 6 shares worth $759. The position accounts for ﹤0.01% of the portfolio, ranked #164.

3 Factor Indexing first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $837 in Q1 2026. 2,169 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • 3 Factor Indexing held 6 shares of Gilead Sciences worth $759 as of Q2 2026.
  • 3 Factor Indexing left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of 3 Factor Indexing's portfolio in Q2 2026, its #164 holding.
  • 3 Factor Indexing first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • 3 Factor Indexing's Gilead Sciences position peaked at $837 in Q1 2026.
  • 2,169 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on 3 Factor Indexing's 13F filing for Q2 2026, filed 8 Jul 2026.